Senti Biosciences (NASDAQ:SNTI) Issues Earnings Results

Senti Biosciences (NASDAQ:SNTI) released its quarterly earnings results on Thursday. The company reported ($0.67) earnings per share for the quarter, Zacks reports.

Senti Biosciences Stock Performance

Shares of Senti Biosciences stock traded down $0.11 during trading hours on Thursday, reaching $3.51. The company’s stock had a trading volume of 16,801 shares, compared to its average volume of 781,284. The company has a market capitalization of $16.95 million, a P/E ratio of -0.23 and a beta of 2.52. The stock’s fifty day simple moving average is $3.95 and its two-hundred day simple moving average is $3.44. Senti Biosciences has a one year low of $1.52 and a one year high of $16.94.

Analyst Ratings Changes

Separately, Chardan Capital reiterated a “buy” rating and issued a $10.00 target price on shares of Senti Biosciences in a report on Monday, December 2nd.

About Senti Biosciences

Senti Biosciences, Inc operates as a preclinical biotechnology company that develops next-generation cell and gene therapies engineered with its gene circuit platform technologies for various diseases. Its lead product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications.